X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (28) 28
index medicus (21) 21
child (19) 19
female (18) 18
male (18) 18
urology & nephrology (18) 18
adolescent (13) 13
child, preschool (12) 12
pediatrics (11) 11
mutations (9) 9
medicine & public health (8) 8
atypical hemolytic uremic syndrome (7) 7
infant (7) 7
mutation (7) 7
nephrology (7) 7
thrombotic thrombocytopenic purpura (7) 7
treatment outcome (7) 7
adult (6) 6
complement (6) 6
eculizumab (6) 6
hemolytic-uremic syndrome - immunology (6) 6
infant, newborn (6) 6
hemolytic-uremic syndrome (5) 5
kidney transplantation (5) 5
life sciences (5) 5
risk factors (5) 5
thrombotic microangiopathy (5) 5
care and treatment (4) 4
children (4) 4
cohort studies (4) 4
disease (4) 4
france (4) 4
hemolytic-uremic syndrome - diagnosis (4) 4
hemolytic-uremic syndrome - therapy (4) 4
human health and pathology (4) 4
plasma exchange (4) 4
retrospective studies (4) 4
therapy (4) 4
young adult (4) 4
ahus (3) 3
alternative pathway (3) 3
animals (3) 3
antibodies (3) 3
antibodies, monoclonal, humanized - administration & dosage (3) 3
complement factor-h (3) 3
cyclosporine (3) 3
diagnosis (3) 3
factor-cleaving protease (3) 3
genetics (3) 3
genetics & heredity (3) 3
hemolytic uremic syndrome (3) 3
hemolytic-uremic syndrome - drug therapy (3) 3
hemolytic-uremic syndrome - epidemiology (3) 3
hemolytic-uremic syndrome - physiopathology (3) 3
immunosuppressive agents - therapeutic use (3) 3
impact (3) 3
internal medicine (3) 3
kidney - pathology (3) 3
phenotype (3) 3
plasmapheresis (3) 3
protein (3) 3
successful plasma therapy (3) 3
transplantation (3) 3
[sdv.mhep]life sciences [q-bio]/human health and pathology (2) 2
age factors (2) 2
aged (2) 2
algorithms (2) 2
analysis (2) 2
antibodies, monoclonal, humanized - adverse effects (2) 2
antibodies, monoclonal, humanized - therapeutic use (2) 2
atypical hemolytic uremic syndrome - drug therapy (2) 2
atypical hemolytic uremic syndrome - immunology (2) 2
autosomal recessive polycystic kidney disease (2) 2
binding (2) 2
c3 (2) 2
chronic kidney disease (2) 2
clinical medicine (2) 2
clinical trial (2) 2
complement activation (2) 2
complement activation - drug effects (2) 2
complement c3 - genetics (2) 2
complement factor h (2) 2
complement factor h - immunology (2) 2
complement inactivating agents - therapeutic use (2) 2
complement inhibitor eculizumab (2) 2
complement system proteins - genetics (2) 2
complement system proteins - immunology (2) 2
complement-factor-h (2) 2
complications and side effects (2) 2
deficiency (2) 2
dense-deposit disease (2) 2
drugs (2) 2
expression (2) 2
factor b (2) 2
factor i (2) 2
factor-h antibodies (2) 2
factor-i (2) 2
gene (2) 2
genetic predisposition to disease (2) 2
genetic variation (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Journal of Kidney Diseases, ISSN 0272-6386, 2013, Volume 63, Issue 1, pp. 40 - 48
Journal Article
Journal Article
Journal Article
Orphanet Journal of Rare Diseases, ISSN 1750-1172, 2011, Volume 6, Issue 1, pp. 60 - 60
Hemolytic uremic syndrome (HUS) is defined by the triad of mechanical hemolytic anemia, thrombocytopenia and renal impairment. Atypical HUS (aHUS) defines non... 
C3 | Plasma exchange | Factor H | Combined liver-kidney transplantation | Plasma infusion | Factor B | Atypical hemolytic uremic syndrome | Eculizumab | Membrane cofactor protein | Thrombomodulin | Factor I | Kidney transplantation | MEDICINE, RESEARCH & EXPERIMENTAL | factor I | CFHR1/CFHR3 DEFICIENCY | LIVER-KIDNEY TRANSPLANTATION | plasma infusion | kidney transplantation | eculizumab | factor B | THROMBOTIC THROMBOCYTOPENIC PURPURA | SUCCESSFUL RENAL-TRANSPLANTATION | factor H | combined liver-kidney transplantation | INHIBITOR ECULIZUMAB | ALTERNATIVE PATHWAY | membrane cofactor protein | thrombomodulin | GENETICS & HEREDITY | plasma exchange | SUCCESSFUL PLASMA THERAPY | FACTOR-I MUTATIONS | COMPLEMENT-FACTOR-H | Complement Activation | Humans | Middle Aged | Child, Preschool | Complement System Proteins - immunology | Infant | Male | Hemolytic-Uremic Syndrome - epidemiology | Young Adult | Hemolytic-Uremic Syndrome - genetics | Hemolytic-Uremic Syndrome - physiopathology | Aged, 80 and over | Adult | Complement System Proteins - genetics | Female | Hemolytic-Uremic Syndrome - therapy | Child | Infant, Newborn | Risk Factors | Kidney Transplantation | Animals | Adolescent | Aged | Mice | Mutation | Atypical Hemolytic Uremic Syndrome | Viral antibodies | Usage | Care and treatment | Antibodies | Genetic aspects | Research | Diagnosis | Health aspects | Genetic screening | Hemolytic-uremic syndrome | Risk factors | Lupus | Plasma | E coli | Disease | Vascular endothelial growth factor | Streptococcus infections
Journal Article
Journal Article
Pediatric Nephrology, ISSN 0931-041X, 2009, Volume 24, Issue 4, pp. 687 - 696
Journal Article